Company Filing History:
Years Active: 2015-2024
Title: **Nicolas Otto Krogh: Innovator in Molecular Imprinting Technology**
Introduction
Nicolas Otto Krogh, based in Virum, Denmark, is a dedicated inventor known for his innovative contributions in the field of molecular imprinting technology. With a total of five patents to his name, his work significantly impacts the understanding and treatment of metabolic disorders.
Latest Patents
Krogh's most notable recent patents include:
1. **Molecular Imprinted Polymers Targeting Phenylalanine** - This inventive disclosure outlines agents and methods that address metabolic malfunctions, both inborn and acquired. The invention particularly focuses on the preparation methods of molecular imprinted polymers (MIPs) with high binding capacity for phenylalanine or tyrosine. Furthermore, it presents methods for treating conditions such as phenylketonuria, alkaptonuria, and hypertyrosinemia.
2. **Detection Method and Means Therefor** - This patent introduces a FRET-based assay employing molecular imprinted polymers that exhibit a very high affinity for their target. The assay enhances detection capabilities in various applications relating to metabolic disorders.
Career Highlights
Nicolas Otto Krogh is associated with Mipsalus ApS, a company recognized for its dedication to advancing molecular imprinting technology and its applications in healthcare. His work at Mipsalus ApS reflects his commitment to improving therapeutic methods and enhancing patient care.
Collaborations
Throughout his career, Krogh has collaborated with distinguished colleagues, including Klaus Gregorius and Ian Alan Nicholls. These partnerships highlight the value of teamwork in driving innovation and developing new solutions in scientific research and technology.
Conclusion
Nicolas Otto Krogh's contributions to molecular imprinting technology and his active role in developing impactful medical treatments emphasize his significance as an inventor. His ongoing work continues to inspire advancements in the field, marking him as a key figure in contemporary scientific innovation.